Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Del Rosso

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Rheumatology|June 14, 2012
CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosisPaolo Sfriso, Franco Cozzi, Francesca Oliviero, et al.
Nitric Oxide : Biology and Chemistry|November 26, 2002
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosisPaola Failli, Loredana Palmieri, Caterina D'Alfonso, et al.
Therapeutic Advances in Musculoskeletal Disease|June 24, 2021
Rehabilitation of the face and temporomandibular joint in systemic sclerosisSusanna Maddali Bongi, Mauro Passalacqua, Giovanna Landi, et al.
International Journal of Cancer|April 1, 2004
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in miceSilvia D'Alessio, Francesca Margheri, Marco Pucci, et al.
International Journal of Oncology|June 9, 2005
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat proteinFrancesca Margheri, Silvia D'Alessio, Simona Serratì, et al.
The Journal of Rheumatology|June 5, 2003
Pupillocynetic activity of substance P in systemic sclerosisAngela Del Rosso, Luca Bertinotti, Umberto Pietrini, et al.
Rheumatology International|March 5, 2004
Neprilysin levels in plasma and synovial fluid of juvenile idiopathic arthritis patientsGabriele Simonini, Chiara Azzari, Anna Maria Grazia Gelli, et al.
Arthritis and Rheumatism|June 10, 2004
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markersAngela Del Rosso, Maura Boldrini, David D'Agostino, et al.
Arthritis Research|November 28, 2002
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcersOliver Distler, Angela Del Rosso, Roberto Giacomelli, et al.
Journal of Pineal Research|August 2, 2006
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosisAlberto Moggi Pignone, Angela Del Rosso, Ginevra Fiori, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Rheumatology|June 14, 2012
CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosisPaolo Sfriso, Franco Cozzi, Francesca Oliviero, et al.
Nitric Oxide : Biology and Chemistry|November 26, 2002
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosisPaola Failli, Loredana Palmieri, Caterina D'Alfonso, et al.
Therapeutic Advances in Musculoskeletal Disease|June 24, 2021
Rehabilitation of the face and temporomandibular joint in systemic sclerosisSusanna Maddali Bongi, Mauro Passalacqua, Giovanna Landi, et al.
International Journal of Cancer|April 1, 2004
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in miceSilvia D'Alessio, Francesca Margheri, Marco Pucci, et al.
International Journal of Oncology|June 9, 2005
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat proteinFrancesca Margheri, Silvia D'Alessio, Simona Serratì, et al.
The Journal of Rheumatology|June 5, 2003
Pupillocynetic activity of substance P in systemic sclerosisAngela Del Rosso, Luca Bertinotti, Umberto Pietrini, et al.
Rheumatology International|March 5, 2004
Neprilysin levels in plasma and synovial fluid of juvenile idiopathic arthritis patientsGabriele Simonini, Chiara Azzari, Anna Maria Grazia Gelli, et al.
Arthritis and Rheumatism|June 10, 2004
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markersAngela Del Rosso, Maura Boldrini, David D'Agostino, et al.
Arthritis Research|November 28, 2002
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcersOliver Distler, Angela Del Rosso, Roberto Giacomelli, et al.
Journal of Pineal Research|August 2, 2006
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosisAlberto Moggi Pignone, Angela Del Rosso, Ginevra Fiori, et al.
Pageof 5